Veterinary Vaccine Is Developed For Protecting Livestock and Companion Animals from Various Infectious Diseases
There are a variety of different types of veterinary
vaccines. Some are inactivated while others are live. Live products are
typically used in the prevention of bacterial diseases in animals, however, there
are some drawbacks. Live products do not have adjuvants, which can reduce their
effectiveness.
Global
Veterinary Vaccines Market
is estimated to be valued at US$ 8,482.6
million in 2022 and is expected to exhibit a CAGR of 6.2% during the forecast period (2022-2030).
The major goals of veterinary vaccine development are to
protect livestock and companion animals from a wide range of infectious
diseases. Other goals include preventing the transmission of animal-to-human
diseases and enhancing animal production. The development process for
veterinary vaccines involves various approaches, from crude however, effective
whole pathogen preparations to the use of vectored antigen formulations and
naked DNA injections.
Veterinary
vaccine development has several advantages
over human vaccine development. One major advantage of developing vaccines for
animals is that researchers can begin their studies in the target species
immediately. Another advantage of veterinary vaccine development is that there
is no need for rodent models. Further, new vaccines can be developed that
combat diseases that are currently not common among animals.
Several government initiatives are driving the growth of the
veterinary vaccine. In the U.K., for example, the Department of Environment,
Food and Rural Affairs has given permission to a government research
organization to conduct field trials on bovine tuberculosis cattle vaccination.
The trials will run for four years, from 2021 to 2024. The government of Wales,
Scotland, and the Department of Environment will participate in the trials.
Veterinary Vaccine is an open access journal that publishes
papers on vaccinology research in animals. The journal focuses on all aspects
of vaccinology, including the development and safety of vaccines. It encourages
the submission of original research articles and communications on the topic.
Vaccines are a cost-effective way to improve animal welfare and food
production. In September 2022, Tiba Biotech, and an Australian State government
of New South Wales entered into five-year, agreement for the development of
next-generation mRNA vaccines against emergency animal diseases threatening
livestock industry of the country.
Comments
Post a Comment